Investor Overview

Satsuma Pharmaceuticals Investor Relations

Corporate Presentation

Download

 

Recent News
May 27, 2020

South San Francisco, CA, May 27, 2020 – Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA) a clinical-stage biopharmaceutical company, today announced that John Kollins, President and Chief Executive...

May 18, 2020

South San Francisco, CA, May 18, 2020 – Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA) a clinical-stage biopharmaceutical company, today announced that two abstracts and scientific presentations...

May 12, 2020

South San Francisco, CA, May 12, 2020 – Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company, today reported financial results for the first quarter 2020 and...

Stock Info
NASDAQSTSA